Investors

GENBAND would like to acknowledge and thank our other investors: Investcorp Technology Ventures, Thomas Weisel Partners, Intel Capital, JVP, Trellis Partners, GGV Capital, Summerhill Venture Partners, INVESCO Private Capital Group, Telesoft Partners, Core Capital Partners, Siemens Venture Capital Gmbtt, The Wellcome Trust, and Columbia Partners Private Capital.

One Equity Partners

Established in 2001, OEP manages $8 billion of investments and commitments for JPMorgan Chase & Co. in direct private equity transactions. Partnering with management, OEP invests in transactions that initiate strategic and operational changes in businesses to create long-term value. OEP's investment professionals are located across North America, Europe and Asia, with offices in New York, Chicago, Menlo Park, Frankfurt and Hong Kong. Over recent years, OEP has invested approximately $4 billion to acquire over forty companies in a variety of industries including defense, chemicals, healthcare, technology, travel and manufacturing.

Oak Investment Partners

Oak Investment Partners was founded in 1978 and has raised nine venture capital partnerships with a total of $2.6 billion in committed capital. Oak has sponsored over 300 companies with aggregate annual revenues in excess of $70 billion.

Sevin Rosen Funds

Founded in 1981, Sevin Rosen Funds is a top-tier venture capital firm with a successful track record of funding early-stage ventures. SRF partners have a recognized history of helping entrepreneurs convert their concepts into well-managed, successful businesses. Over the past twenty-one years, SRF has employed a unique blend of technical vision and operational expertise to identify, at a very early stage, the potential of such companies as Compaq, Lotus Development, Cypress Semiconductor, Citrix, CIENA, and Capstone Turbine.

Venrock

Venrock is a premier venture capital firm with offices in Menlo Park, New York, Cambridge, MA, and Israel. Originally established as the venture capital arm of the Rockefeller family, Venrock continues a seven-decade tradition of partnering with entrepreneurs to establish successful, enduring companies. Having invested $1.9 billion in 405 companies resulting in over 120 IPOs over the past 39 years, Venrock’s investment returns place it among the top tier venture capital firms that have achieved consistently superior performance. With a primary focus on technology, healthcare, and energy, portfolio companies have included Adnexus Therapeutics, Apple Computer, Centocor, Check Point Software, DoubleClick, Gilead Sciences, Idec Pharmaceuticals, Illumina, Intel, Millennium Pharmaceuticals, Sirna Therapeutics, StrataCom, and Vontu. For more information, please visit Venrock’s website at www.venrock.com.

GENBAND leads the global IP Communications industry, offering end-to-end network solutions including market-leading Switching, Applications, Networking and Service solutions.
©2012 GENBAND All Rights Reserved.
HOME | SITE MAP | LEGAL | ENVIRONMENT